Logo image of NNOX

NANO-X IMAGING LTD (NNOX) Stock Fundamental Analysis

NASDAQ:NNOX - IL0011681371 - Common Stock

3.89 USD
+0.11 (+2.91%)
Last: 9/11/2025, 9:40:48 AM
Fundamental Rating

4

NNOX gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. No worries on liquidiy or solvency for NNOX as it has an excellent financial health rating, but there are worries on the profitability. NNOX is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

NNOX had negative earnings in the past year.
In the past year NNOX has reported a negative cash flow from operations.
NNOX had negative earnings in each of the past 5 years.
In the past 5 years NNOX always reported negative operating cash flow.
NNOX Yearly Net Income VS EBIT VS OCF VS FCFNNOX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -30.21%, NNOX is doing worse than 85.15% of the companies in the same industry.
The Return On Equity of NNOX (-34.03%) is worse than 69.31% of its industry peers.
Industry RankSector Rank
ROA -30.21%
ROE -34.03%
ROIC N/A
ROA(3y)-32.63%
ROA(5y)-26.69%
ROE(3y)-37.21%
ROE(5y)-30.36%
ROIC(3y)N/A
ROIC(5y)N/A
NNOX Yearly ROA, ROE, ROICNNOX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for NNOX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NNOX Yearly Profit, Operating, Gross MarginsNNOX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 -1K -2K -3K -4K

More info and screens

8

2. Health

2.1 Basic Checks

NNOX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NNOX has been increased compared to 1 year ago.
Compared to 5 years ago, NNOX has more shares outstanding
NNOX has a better debt/assets ratio than last year.
NNOX Yearly Shares OutstandingNNOX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
NNOX Yearly Total Debt VS Total AssetsNNOX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 3.28 indicates that NNOX is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.28, NNOX is in the better half of the industry, outperforming 68.32% of the companies in the same industry.
NNOX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.28
ROIC/WACCN/A
WACC8.75%
NNOX Yearly LT Debt VS Equity VS FCFNNOX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

A Current Ratio of 4.19 indicates that NNOX has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 4.19, NNOX belongs to the top of the industry, outperforming 90.10% of the companies in the same industry.
NNOX has a Quick Ratio of 4.03. This indicates that NNOX is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of NNOX (4.03) is better than 90.10% of its industry peers.
Industry RankSector Rank
Current Ratio 4.19
Quick Ratio 4.03
NNOX Yearly Current Assets VS Current LiabilitesNNOX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

7

3. Growth

3.1 Past

NNOX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.17%, which is quite good.
Looking at the last year, NNOX shows a quite strong growth in Revenue. The Revenue has grown by 17.36% in the last year.
The Revenue has been growing by 105.51% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)17.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)17.36%
Revenue growth 3Y105.51%
Revenue growth 5YN/A
Sales Q2Q%12.63%

3.2 Future

NNOX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.59% yearly.
Based on estimates for the next years, NNOX will show a very strong growth in Revenue. The Revenue will grow by 69.79% on average per year.
EPS Next Y-9.46%
EPS Next 2Y21.38%
EPS Next 3Y19.82%
EPS Next 5Y27.59%
Revenue Next Year15.53%
Revenue Next 2Y73.5%
Revenue Next 3Y56.68%
Revenue Next 5Y69.79%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
NNOX Yearly Revenue VS EstimatesNNOX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M 500M
NNOX Yearly EPS VS EstimatesNNOX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NNOX. In the last year negative earnings were reported.
Also next year NNOX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NNOX Price Earnings VS Forward Price EarningsNNOX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NNOX Per share dataNNOX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

A more expensive valuation may be justified as NNOX's earnings are expected to grow with 19.82% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.38%
EPS Next 3Y19.82%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NNOX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NANO-X IMAGING LTD

NASDAQ:NNOX (9/11/2025, 9:40:48 AM)

3.89

+0.11 (+2.91%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-12 2025-08-12/bmo
Earnings (Next)11-19 2025-11-19/bmo
Inst Owners24.69%
Inst Owner Change-16.96%
Ins Owners0.23%
Ins Owner Change16.81%
Market Cap248.73M
Analysts84
Price Target7.91 (103.34%)
Short Float %11.42%
Short Ratio5.87
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-12.82%
Min EPS beat(2)-18.68%
Max EPS beat(2)-6.95%
EPS beat(4)2
Avg EPS beat(4)1.75%
Min EPS beat(4)-18.68%
Max EPS beat(4)32.13%
EPS beat(8)4
Avg EPS beat(8)5.75%
EPS beat(12)6
Avg EPS beat(12)-0.97%
EPS beat(16)7
Avg EPS beat(16)-8.53%
Revenue beat(2)0
Avg Revenue beat(2)-18.84%
Min Revenue beat(2)-30.68%
Max Revenue beat(2)-7.01%
Revenue beat(4)0
Avg Revenue beat(4)-19.03%
Min Revenue beat(4)-30.68%
Max Revenue beat(4)-7.01%
Revenue beat(8)0
Avg Revenue beat(8)-24.4%
Revenue beat(12)0
Avg Revenue beat(12)-22.33%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-11.43%
PT rev (3m)-22.5%
EPS NQ rev (1m)-12.28%
EPS NQ rev (3m)-33.33%
EPS NY rev (1m)-11.75%
EPS NY rev (3m)-19.73%
Revenue NQ rev (1m)-3.07%
Revenue NQ rev (3m)-61.01%
Revenue NY rev (1m)0.24%
Revenue NY rev (3m)-27.65%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 20.93
P/FCF N/A
P/OCF N/A
P/B 1.52
P/tB 2.52
EV/EBITDA N/A
EPS(TTM)-0.82
EYN/A
EPS(NY)-0.43
Fwd EYN/A
FCF(TTM)-0.65
FCFYN/A
OCF(TTM)-0.6
OCFYN/A
SpS0.19
BVpS2.56
TBVpS1.55
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -30.21%
ROE -34.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-32.63%
ROA(5y)-26.69%
ROE(3y)-37.21%
ROE(5y)-30.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 28.45%
Cap/Sales 28.15%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.19
Quick Ratio 4.03
Altman-Z 3.28
F-Score3
WACC8.75%
ROIC/WACCN/A
Cap/Depr(3y)37.93%
Cap/Depr(5y)1552.65%
Cap/Sales(3y)47.15%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y-9.46%
EPS Next 2Y21.38%
EPS Next 3Y19.82%
EPS Next 5Y27.59%
Revenue 1Y (TTM)17.36%
Revenue growth 3Y105.51%
Revenue growth 5YN/A
Sales Q2Q%12.63%
Revenue Next Year15.53%
Revenue Next 2Y73.5%
Revenue Next 3Y56.68%
Revenue Next 5Y69.79%
EBIT growth 1Y-5.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y10.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y11.22%
OCF growth 3YN/A
OCF growth 5YN/A